Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05730816
PHASE2

MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI

Sponsor: Brigham and Women's Hospital

View on ClinicalTrials.gov

Summary

In this research study, investigators will test whether prophylactic high-dose IV Mg administration attenuates the risk of AKI in patients with malignant mesothelioma receiving intraoperative chemotherapy (HIOC) with cisplatin compared to placebo .

Official title: MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2023-04-04

Completion Date

2028-01-01

Last Updated

2025-11-21

Healthy Volunteers

No

Conditions

Interventions

DRUG

Magnesium sulfate

Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin.

DRUG

Normal Saline

Intravenous infusion of normal saline.

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States